Matthias Schmitz

5.1k total citations
112 papers, 2.7k citations indexed

About

Matthias Schmitz is a scholar working on Molecular Biology, Neurology and Neurology. According to data from OpenAlex, Matthias Schmitz has authored 112 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Molecular Biology, 46 papers in Neurology and 34 papers in Neurology. Recurrent topics in Matthias Schmitz's work include Prion Diseases and Protein Misfolding (76 papers), Neurological diseases and metabolism (36 papers) and Alzheimer's disease research and treatments (27 papers). Matthias Schmitz is often cited by papers focused on Prion Diseases and Protein Misfolding (76 papers), Neurological diseases and metabolism (36 papers) and Alzheimer's disease research and treatments (27 papers). Matthias Schmitz collaborates with scholars based in Germany, Spain and United Kingdom. Matthias Schmitz's co-authors include Inga Zerr, Franc Llorens, Saima Zafar, Daniela Varges, Maria Cramm, Péter Hermann, Anna Villar‐Piqué, Isidró Ferrer, André Karch and Walter Schulz‐Schaeffer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Neuroscience.

In The Last Decade

Matthias Schmitz

106 papers receiving 2.7k citations

Peers

Countries citing papers authored by Matthias Schmitz

Since Specialization

Citations

This map shows the geographic impact of Matthias Schmitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Schmitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Schmitz more than expected).

Fields of papers citing papers by Matthias Schmitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Schmitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Schmitz. The network helps show where Matthias Schmitz may publish in the future.

Co-authorship network of co-authors of Matthias Schmitz

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Schmitz. A scholar is included among the top collaborators of Matthias Schmitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Schmitz. Matthias Schmitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Alpha‐Synuclein Demonstrates Varying Binding Affinities With Different Tau Isoforms 2025 ·Journal of Neurochemistry ·(unknown), Matthias Schmitz, (unknown), Saima Zafar, Neelam Younas, (unknown), Angela da Silva Correia, (unknown), Inga Zerr	2
2	A Comparison of RML Prion Inactivation Efficiency by Heterogeneous and Homogeneous Photocatalysis 2024 ·Pathogens ·Ioannis Paspaltsis, Ειrini Kanata, (unknown), (unknown), Matthias Schmitz, Inga Zerr, Dimitra Dafou, Konstantinos Xanthopoulos, Theodoros Sklaviadis	1
3	SIMOA Diagnostics on Alzheimer’s Disease and Frontotemporal Dementia 2024 ·Biomedicines ·(unknown), (unknown), Ειrini Kanata, Kostas Vekrellis, Vasilios C. Constantinides, George P. Paraskevas, (unknown), Matthias Schmitz, Inga Zerr, Konstantinos Xanthopoulos, Theodoros Sklaviadis, Dimitra Dafou	5
4	Current Technologies Unraveling the Significance of Post-Translational Modifications (PTMs) as Crucial Players in Neurodegeneration 2024 ·Biomolecules ·Saima Zafar, (unknown), Matthias Schmitz, Inga Zerr	16
5	Synthesis, structural characterization and study of antioxidant and anti-PrPSc properties of flavonoids and their rhenium(I)–tricarbonyl complexes 2023 ·JBIC Journal of Biological Inorganic Chemistry ·(unknown), (unknown), Konstantinos Xanthopoulos, (unknown), Susana Correia, (unknown), Katrin Thüne, Antonios G. Hatzidimitriou, Inga Zerr, Matthias Schmitz, Theodoros Sklaviadis, Dimitra Hadjipavlou‐Litina, Dionysia Papagiannopoulou	3
6	Application of real-time quaking-induced conversion in Creutzfeldt–Jakob disease surveillance 2023 ·Journal of Neurology ·Péter Hermann, Matthias Schmitz, Maria Cramm, Stefan Goebel, (unknown), (unknown), Walter Schulz‐Schaeffer, Christine Stadelmann, Jakob Matschke, Markus Glatzel, Inga Zerr	5
7	Genetic Variants Associated with the Age of Onset Identified by Whole-Exome Sequencing in Fatal Familial Insomnia 2023 ·Cells ·Katrin Thüne, Matthias Schmitz, (unknown), Orr Shomroni, Stefan Göbel, (unknown), Neelam Younas, Saima Zafar, Péter Hermann, Inga Zerr	1
8	Role of different recombinant PrP substrates in the diagnostic accuracy of the CSF RT-QuIC assay in Creutzfeldt-Jakob disease 2022 ·Cell and Tissue Research ·Susana Correia, Matthias Schmitz, André Fischer, Péter Hermann, Inga Zerr	3
9	SWATH Mass Spectrometry-Based CSF Proteome Profile of GBA-Linked Parkinson’s Disease Patients 2022 ·International Journal of Molecular Sciences ·Saima Zafar, (unknown), Neelam Younas, Mohsin Shafiq, Matthias Schmitz, Isabel Wurster, Kathrin Brockmann, Thomas Gasser, Inga Zerr	4
10	Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease 2022 ·Molecular Neurobiology ·Matthias Schmitz, (unknown), Juan Carlos Espinosa, Natalia Fernández‐Borges, Anna Villar‐Piqué, Franc Llorens, Daniela Varges, Fabian Maass, Juan María Torres, Péter Hermann, Inga Zerr	8
11	Carnosic Acid and Carnosol Display Antioxidant and Anti-Prion Properties in In Vitro and Cell-Free Models of Prion Diseases 2022 ·Antioxidants ·(unknown), (unknown), Ειrini Kanata, (unknown), Katrin Thüne, Matthias Schmitz, Ioannis Tsamesidis, Evgenia Lymperaki, Konstantinos Xanthopoulos, Theodoros Sklaviadis, Dimitra Dafou	21
12	Cellular Prion Protein Mediates α‐Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo 2021 ·Movement Disorders ·(unknown), Matthias Schmitz, (unknown), Angela da Silva Correia, Susana Correia, Franc Llorens, (unknown), Wiebke Möbius, (unknown), Saima Zafar, Erik Stoops, Christopher J. Silva, André Fischer, Tiago F. Outeiro, Inga Zerr	17
13	Altered mRNA and Protein Expression of Monocarboxylate Transporter MCT1 in the Cerebral Cortex and Cerebellum of Prion Protein Knockout Mice 2021 ·International Journal of Molecular Sciences ·Sanja Ramljak, Matthias Schmitz, Cendrine Repond, Inga Zerr, Luc Pellerin	6
14	Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays 2020 ·Translational Neurodegeneration ·Niccolò Candelise, Matthias Schmitz, Katrin Thüne, Maria Cramm, Alberto Rábano, Saima Zafar, Erik Stoops, Hugo Vanderstichele, Anna Villar‐Piqué, Franc Llorens, Inga Zerr	57
15	Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency 2019 ·Molecular Neurobiology ·Matthias Schmitz, Niccolò Candelise, Ειrini Kanata, Franc Llorens, Katrin Thüne, Anna Villar‐Piqué, Susana Correia, Dimitra Dafou, Theodoros Sklaviadis, Dietmar Appelhans, Inga Zerr	14
16	Plasma YKL-40 in the spectrum of neurodegenerative dementia 2019 ·Journal of Neuroinflammation ·Anna Villar‐Piqué, Matthias Schmitz, Péter Hermann, Stefan Goebel, (unknown), Daniela Varges, Isidró Ferrer, J. Riggert, Franc Llorens, Inga Zerr	51
17	CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD 2019 ·Journal of Neurology Neurosurgery & Psychiatry ·Kaj Blennow, Daniela Díaz‐Lucena, Henrik Zetterberg, Anna Villar‐Piqué, André Karch, Enríc Vidal, Péter Hermann, Matthias Schmitz, (unknown), Inga Zerr, Franc Llorens	52
18	Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients 2019 ·Biomolecules ·Inga Zerr, Anna Villar‐Piqué, (unknown), Anna Poleggi, Maurizio Pocchiari, Raquel Sánchez‐Valle, Miguel Calero, Olga Calero, Inês Baldeiras, Isabel Santana, Gábor G. Kovács, Franc Llorens, Matthias Schmitz	10
19	Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and Synucleinopathy 2018 ·Molecular Neurobiology ·Matthias Schmitz, Anna Villar‐Piqué, Franc Llorens, Karin Gmitterová, Péter Hermann, Daniela Varges, Saima Zafar, Paul Lingor, Hugo Vanderstichele, (unknown), Erik Stoops, John Q. Trojanowski, Virginia M.‐Y. Lee, Inga Zerr	23
20	Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases 2018 ·Molecular Neurobiology ·Anna Villar‐Piqué, Matthias Schmitz, Niccolò Candelise, Salvador Ventura, Franc Llorens, Inga Zerr	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact